Skip to main content
Top
Published in: Journal of Gastroenterology 12/2020

01-12-2020 | Endoscopy | Original Article—Alimentary Tract

Near-focus magnification and second-generation narrow-band imaging for early gastric cancer in a randomized trial

Authors: Naomi Kakushima, Naohiro Yoshida, Hisashi Doyama, Tomonori Yano, Takahiro Horimatsu, Noriya Uedo, Yoshinobu Yamamoto, Hiromitsu Kanzaki, Shinichiro Hori, Kenshi Yao, Ichiro Oda, Satoshi Tanabe, Chizu Yokoi, Ken Ohata, Kenichi Yoshimura, Hideki Ishikawa, Manabu Muto

Published in: Journal of Gastroenterology | Issue 12/2020

Login to get access

Abstract

Background

Magnifying endoscopy with narrow-band imaging (NBI) is effective for the diagnosis of early gastric cancer (EGC). However, magnifying endoscopy is not yet popular globally because of the required level of skill and lack of availability. To overcome these problems, dual-focus endoscopy (standard- and near-focus (NF) modes) has been developed. In this study, we evaluated the diagnostic performance of NF with second-generation (2G)-NBI (NF-NBI) for the diagnosis of EGC.

Methods

This was a secondary analysis of a multicenter randomized controlled trial of 4523 high-risk patients who underwent gastroscopies at 13 institutions in Japan. Patients were randomly assigned to white-light imaging (WLI) followed by 2G-NBI or to 2G-NBI followed by WLI. Lesions suspicious for EGC, newly detected by non-magnifying WLI or 2G-NBI, were subsequently observed with NF-NBI. All detected lesions were biopsied or resected. The diagnostic performance of NF-NBI was compared with the final histology.

Results

A total of 870 detected lesions (145 EGC, 725 non-EGC) were analyzed. Overall diagnostic performance for EGC using NF-NBI was accuracy 87.7%, sensitivity 60.7%, specificity 93.1%, positive predictive value 63.8%, and negative predictive value 92.2%. There were no significant differences in diagnostic performance between lesions detected by WLI or 2G-NBI. For lesions diagnosed with high (333 lesions) and low (537 lesions) confidences, accuracy was 92.2% and 84.9%, sensitivity was 64.7% and 58.5%, and specificity was 90.5% and 88.8%, respectively.

Conclusion

The diagnostic performance of NF-NBI is good and acceptable for diagnosis of EGC in combination with either WLI or 2G-NBI.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, et al. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRef Bray F, Ferlay J, Soerjomataram I, et al. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRef
2.
go back to reference Zhang X, Li M, Chen S, et al. Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: a meta-analysis and systematic review. Gastroenterology. 2018;155:347–54.CrossRef Zhang X, Li M, Chen S, et al. Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: a meta-analysis and systematic review. Gastroenterology. 2018;155:347–54.CrossRef
3.
go back to reference Banks M, Graham D, Jansen M, et al. British society of gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019;68:1545–75.CrossRef Banks M, Graham D, Jansen M, et al. British society of gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019;68:1545–75.CrossRef
4.
go back to reference Pimentel-Nunes P, Libanio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European society of gastrointestinal endoscopy (ESGE), European helicobacter and microbiota study group (EHMSG), European society of pathology (ESD), and Sociedade portuguesa de endoscopia digestiva (SPE) guideline update 2019. Endoscopy. 2019;51:365–8.CrossRef Pimentel-Nunes P, Libanio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European society of gastrointestinal endoscopy (ESGE), European helicobacter and microbiota study group (EHMSG), European society of pathology (ESD), and Sociedade portuguesa de endoscopia digestiva (SPE) guideline update 2019. Endoscopy. 2019;51:365–8.CrossRef
5.
go back to reference Nakayoshi T, Tajiri H, Matsuda K, et al. Magnifying endoscopy combined with narrow band imaging system for early gastric cancer: correlation of vascular pattern with histopathology (including video). Endoscopy. 2004;36:1080–4.CrossRef Nakayoshi T, Tajiri H, Matsuda K, et al. Magnifying endoscopy combined with narrow band imaging system for early gastric cancer: correlation of vascular pattern with histopathology (including video). Endoscopy. 2004;36:1080–4.CrossRef
6.
go back to reference Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009;41:462–7.CrossRef Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009;41:462–7.CrossRef
7.
go back to reference Kato M, Kaise M, Yonezawa J, et al. Magnifying endoscopy with narrow-band imaging achieves superior accuracy in the differential diagnosis of superficial gastric lesions identified with white-light endoscopy: a prospective study. Gastrointest Endosc. 2010;72:523–9.CrossRef Kato M, Kaise M, Yonezawa J, et al. Magnifying endoscopy with narrow-band imaging achieves superior accuracy in the differential diagnosis of superficial gastric lesions identified with white-light endoscopy: a prospective study. Gastrointest Endosc. 2010;72:523–9.CrossRef
8.
go back to reference Ezoe Y, Muto M, Uedo N, et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology. 2011;141:2017–25.CrossRef Ezoe Y, Muto M, Uedo N, et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology. 2011;141:2017–25.CrossRef
9.
go back to reference Li H, Dai J, Xue H, et al. Application of magnifying endoscopy with narrow-band imaging in diagnosing gastric lesions: a prospective study. Gastrointest Endosc. 2012;76:1124–32.CrossRef Li H, Dai J, Xue H, et al. Application of magnifying endoscopy with narrow-band imaging in diagnosing gastric lesions: a prospective study. Gastrointest Endosc. 2012;76:1124–32.CrossRef
10.
go back to reference Yao K, Doyama H, Gotoda T, et al. Diagnostic performance and limitation of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: a prospective multicenter feasibility study. Gastric Cancer. 2014;17:669–79.CrossRef Yao K, Doyama H, Gotoda T, et al. Diagnostic performance and limitation of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: a prospective multicenter feasibility study. Gastric Cancer. 2014;17:669–79.CrossRef
11.
go back to reference Zhang Q, Wang F, Chen Z-Y, et al. Comparison of the diagnostic efficacy of white light endoscopy and magnifying endoscopy with narrow-band imaging for early gastric cancer: a meta-analysis. Gastric Cancer. 2016;19:543–52.CrossRef Zhang Q, Wang F, Chen Z-Y, et al. Comparison of the diagnostic efficacy of white light endoscopy and magnifying endoscopy with narrow-band imaging for early gastric cancer: a meta-analysis. Gastric Cancer. 2016;19:543–52.CrossRef
12.
go back to reference Goda K, Dobashi A, Tajiri H. Perspectives on narrow-band imaging endoscopy for superficial squamous neoplasms of the orohypopharynx and esophagus. Dig Endosc. 2014;26(Suppl 1):1–11.CrossRef Goda K, Dobashi A, Tajiri H. Perspectives on narrow-band imaging endoscopy for superficial squamous neoplasms of the orohypopharynx and esophagus. Dig Endosc. 2014;26(Suppl 1):1–11.CrossRef
13.
go back to reference Goda K, Dobashi A, Yoshimura N, et al. Dual-focus versus conventional magnification endoscopy for the diagnosis of superficial squamous neoplasm in the pharynx and esophagus: a randomized trial. Endoscopy. 2016;48:321–9.CrossRef Goda K, Dobashi A, Yoshimura N, et al. Dual-focus versus conventional magnification endoscopy for the diagnosis of superficial squamous neoplasm in the pharynx and esophagus: a randomized trial. Endoscopy. 2016;48:321–9.CrossRef
14.
go back to reference Ikematsu H, Matsuda T, Osera S, et al. Usefulness of narrow-band imaging with dual-focus magnification for differential diagnosis of small colorectal polyp. Surg Endosc. 2015;29:844–50.CrossRef Ikematsu H, Matsuda T, Osera S, et al. Usefulness of narrow-band imaging with dual-focus magnification for differential diagnosis of small colorectal polyp. Surg Endosc. 2015;29:844–50.CrossRef
15.
go back to reference Singh R, Jayanna M, Navadgi S, et al. Narrow-band imaging with dual focus magnification in differentiating colorectal neoplasia. Dig Endosc. 2013;25:16–20.CrossRef Singh R, Jayanna M, Navadgi S, et al. Narrow-band imaging with dual focus magnification in differentiating colorectal neoplasia. Dig Endosc. 2013;25:16–20.CrossRef
18.
go back to reference Nunobe S, Oda I, Ishikawa T, et al. Surgical outcomes of elderly patients with Stage I gastric cancer from the nationwide registry of the Japanese Gastric Cancer Association. Gastric Cancer. 2020;23:328–38.CrossRef Nunobe S, Oda I, Ishikawa T, et al. Surgical outcomes of elderly patients with Stage I gastric cancer from the nationwide registry of the Japanese Gastric Cancer Association. Gastric Cancer. 2020;23:328–38.CrossRef
19.
go back to reference Shibuya H, Wakita T, Nakagawa T, et al. The relation between an esophageal cancer and associated cancers in adjacent organs. Cancer. 1995;76:101–5.CrossRef Shibuya H, Wakita T, Nakagawa T, et al. The relation between an esophageal cancer and associated cancers in adjacent organs. Cancer. 1995;76:101–5.CrossRef
20.
go back to reference Natsugoe S, Matsumoto M, Okumura H, et al. Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J Surg. 2005;29:46–9.CrossRef Natsugoe S, Matsumoto M, Okumura H, et al. Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J Surg. 2005;29:46–9.CrossRef
21.
go back to reference Shimizu H, Okada M, Tangoku A, et al. Thoracic and cardiovascular surgeries in Japan during 2017. Gen Thorac Cardiovasc Surg. 2020;68:414–49.CrossRef Shimizu H, Okada M, Tangoku A, et al. Thoracic and cardiovascular surgeries in Japan during 2017. Gen Thorac Cardiovasc Surg. 2020;68:414–49.CrossRef
22.
go back to reference Muto M, Yao K, Kaise M, et al. Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G). Digestive Endosc. 2016;28:379–93.CrossRef Muto M, Yao K, Kaise M, et al. Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G). Digestive Endosc. 2016;28:379–93.CrossRef
23.
go back to reference Dixon MF. Gastrointestinal epithelial neoplasia: vienna revisited. Gut. 2002;51:130–1.CrossRef Dixon MF. Gastrointestinal epithelial neoplasia: vienna revisited. Gut. 2002;51:130–1.CrossRef
24.
go back to reference Tao G, Xing-hua L, Ai-ming Y, et al. Enhanced magnifying endoscopy for differential diagnosis of superficial gastric lesions identified with white-light endoscopy. Gastric Cancer. 2014;17:122–9.CrossRef Tao G, Xing-hua L, Ai-ming Y, et al. Enhanced magnifying endoscopy for differential diagnosis of superficial gastric lesions identified with white-light endoscopy. Gastric Cancer. 2014;17:122–9.CrossRef
25.
go back to reference Dohi O, Yagi N, Majima A, et al. Diagnostic ability of magnifying endoscopy with blue lase imaging for early gastric cancer: a prospective study. Gastric Cancer. 2017;20:297–303.CrossRef Dohi O, Yagi N, Majima A, et al. Diagnostic ability of magnifying endoscopy with blue lase imaging for early gastric cancer: a prospective study. Gastric Cancer. 2017;20:297–303.CrossRef
26.
go back to reference Maki S, Yao K, Nagahama T, et al. Magnifying endoscopy with narrow-band imaging is useful in the differential diagnosis between low-grade adenoma and early cancer of superficial elevated gastric lesions. Gastric Cancer. 2013;16:140–6.CrossRef Maki S, Yao K, Nagahama T, et al. Magnifying endoscopy with narrow-band imaging is useful in the differential diagnosis between low-grade adenoma and early cancer of superficial elevated gastric lesions. Gastric Cancer. 2013;16:140–6.CrossRef
27.
go back to reference Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764–8.CrossRef Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764–8.CrossRef
28.
go back to reference Fukase K, Kato M, Kikuchi S, et al. Japan Gast Study Group: effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomized controlled trial. Lancet. 2008;372:392–7.CrossRef Fukase K, Kato M, Kikuchi S, et al. Japan Gast Study Group: effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomized controlled trial. Lancet. 2008;372:392–7.CrossRef
29.
go back to reference Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378:1085–95.CrossRef Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378:1085–95.CrossRef
30.
go back to reference Take S, Mizuno M, Ishiki K, et al. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol. 2011;46:318–24.CrossRef Take S, Mizuno M, Ishiki K, et al. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol. 2011;46:318–24.CrossRef
31.
go back to reference Abe S, Oda I, Suzuki H, et al. Long-term surveillance and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection. Endoscopy. 2015;47:1113–8.CrossRef Abe S, Oda I, Suzuki H, et al. Long-term surveillance and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection. Endoscopy. 2015;47:1113–8.CrossRef
32.
go back to reference Nagahama T, Yao K, Maki S, et al. Usefulness of magnifying endoscopy with narrow-band imaging for determining the horizontal extent of early gastric cancer when there is an unclear margin by chromoendoscopy. Gastrointest Endosc. 2011;74:1259–67.CrossRef Nagahama T, Yao K, Maki S, et al. Usefulness of magnifying endoscopy with narrow-band imaging for determining the horizontal extent of early gastric cancer when there is an unclear margin by chromoendoscopy. Gastrointest Endosc. 2011;74:1259–67.CrossRef
33.
go back to reference Okada K, Fujisaki J, Kasuga A, et al. Diagnosis of undifferentiated type early gastric cancers by magnification endoscopy with narrow-band imaging. J Gastroenterol Hepatol. 2011;26:1262–9.CrossRef Okada K, Fujisaki J, Kasuga A, et al. Diagnosis of undifferentiated type early gastric cancers by magnification endoscopy with narrow-band imaging. J Gastroenterol Hepatol. 2011;26:1262–9.CrossRef
34.
go back to reference Kobayashi M, Hashimoto S, Nishikura K, et al. Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradication. J Gastroenterol. 2013;48:1332–42.CrossRef Kobayashi M, Hashimoto S, Nishikura K, et al. Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradication. J Gastroenterol. 2013;48:1332–42.CrossRef
35.
go back to reference Kitamura Y, Ito M, Matsu T, et al. Characteristic epithelium with low-grade atypia appears on the surface of gastric cancer after successful Helicobacter pylori eradication therapy. Helicobacter. 2014;19:289–95.CrossRef Kitamura Y, Ito M, Matsu T, et al. Characteristic epithelium with low-grade atypia appears on the surface of gastric cancer after successful Helicobacter pylori eradication therapy. Helicobacter. 2014;19:289–95.CrossRef
36.
go back to reference Masuda K, Urabe Y, Ito M, et al. Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradication therapy. J Gastroenterol. 2019;54:907–15.CrossRef Masuda K, Urabe Y, Ito M, et al. Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradication therapy. J Gastroenterol. 2019;54:907–15.CrossRef
37.
go back to reference Hata K, Ito M, Boda T, et al. Gastric cancer with submucosal invasion after successful Helicobacer pylori eradication: a propensity score-matched analysis of patients with annual patient endoscopic survey. Digestion. 2019;99:59–655.CrossRef Hata K, Ito M, Boda T, et al. Gastric cancer with submucosal invasion after successful Helicobacer pylori eradication: a propensity score-matched analysis of patients with annual patient endoscopic survey. Digestion. 2019;99:59–655.CrossRef
Metadata
Title
Near-focus magnification and second-generation narrow-band imaging for early gastric cancer in a randomized trial
Authors
Naomi Kakushima
Naohiro Yoshida
Hisashi Doyama
Tomonori Yano
Takahiro Horimatsu
Noriya Uedo
Yoshinobu Yamamoto
Hiromitsu Kanzaki
Shinichiro Hori
Kenshi Yao
Ichiro Oda
Satoshi Tanabe
Chizu Yokoi
Ken Ohata
Kenichi Yoshimura
Hideki Ishikawa
Manabu Muto
Publication date
01-12-2020
Publisher
Springer Singapore
Published in
Journal of Gastroenterology / Issue 12/2020
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-020-01734-3

Other articles of this Issue 12/2020

Journal of Gastroenterology 12/2020 Go to the issue

Original Article—Liver, Pancreas, and Biliary Tract

Durable response without recurrence to Tolvaptan improves long-term survival

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.